Literature DB >> 28501253

Resection of the Primary Tumor in Stage IV Colorectal Cancer: When Is It Necessary?

Leandro Feo1, Michael Polcino2, Garrett M Nash3.   

Abstract

Management of metastatic colorectal cancer requires accurate staging and multidisciplinary evaluation, leading to a consensus treatment plan with the ultimate goal of increasing survival and improving the quality of life, while taking into consideration the patient's performance status, disease burden, and goals of care. Since the introduction of multidrug chemotherapeutic regimens, survival of patients with metastatic colorectal cancer has improved. Many patients with unresectable disease are undergoing surgery for asymptomatic primary tumors despite evidence that it is usually a futile intervention. Palliative measures for local control of the primary tumor include colonic stents, laser therapy, and fulguration.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metastatic colorectal cancer; Palliative treatment; Primary tumor resection; Survival

Mesh:

Year:  2017        PMID: 28501253      PMCID: PMC5590838          DOI: 10.1016/j.suc.2017.01.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  59 in total

1.  Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial.

Authors:  Michel Ducreux; David Malka; Jean Mendiboure; Pierre-Luc Etienne; Patrick Texereau; Dominique Auby; Philippe Rougier; Mohamed Gasmi; Marine Castaing; Moncef Abbas; Pierre Michel; Dany Gargot; Ahmed Azzedine; Catherine Lombard-Bohas; Patrick Geoffroy; Bernard Denis; Jean-Pierre Pignon; Laurent Bedenne; Olivier Bouché
Journal:  Lancet Oncol       Date:  2011-09-06       Impact factor: 41.316

2.  A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival.

Authors:  Cillian Clancy; John P Burke; Mitchel Barry; Matthew F Kalady; J Calvin Coffey
Journal:  Ann Surg Oncol       Date:  2014-05-22       Impact factor: 5.344

3.  Electrocoagulation of selected carcinoma of the rectum.

Authors:  E P Salvati; R J Rubin; T E Eisenstat; G O Siemons; J S Mangione
Journal:  Surg Gynecol Obstet       Date:  1988-05

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.

Authors:  A I Sarela; J A Guthrie; M T Seymour; E Ride; P J Guillou; D S O'Riordain
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

6.  Use of surgery among elderly patients with stage IV colorectal cancer.

Authors:  Larissa K F Temple; Lillian Hsieh; W Douglas Wong; Leonard Saltz; Deborah Schrag
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

7.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

Review 9.  Malignant obstruction of the left colon.

Authors:  G T Deans; Z H Krukowski; S T Irwin
Journal:  Br J Surg       Date:  1994-09       Impact factor: 6.939

10.  Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Authors:  Sabine Venderbosch; Johannes H de Wilt; Steven Teerenstra; Olaf J Loosveld; Aart van Bochove; Harm A Sinnige; Geert-Jan M Creemers; Margot E Tesselaar; Linda Mol; Cornelis J A Punt; Miriam Koopman
Journal:  Ann Surg Oncol       Date:  2011-08-06       Impact factor: 5.344

View more
  11 in total

Review 1.  Endoscopic stenting in colorectal cancer.

Authors:  Tian-Zhi Lim; Ker-Kan Tan
Journal:  J Gastrointest Oncol       Date:  2019-12

2.  Impact of anatomic site of distant metastasis on survival in salivary gland cancers.

Authors:  William Tyler Turchan; Mark C Korpics; Michael Rooney; Matthew Koshy; Michael T Spiotto
Journal:  Head Neck       Date:  2021-05-07       Impact factor: 3.821

Review 3.  Primary tumor resection in stage IV unresectable colorectal cancer: what has changed?

Authors:  Michał Pędziwiatr; Magdalena Mizera; Jan Witowski; Piotr Major; Grzegorz Torbicz; Natalia Gajewska; Andrzej Budzyński
Journal:  Med Oncol       Date:  2017-10-30       Impact factor: 3.064

4.  Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.

Authors:  Rong-Xin Zhang; Wen-Juan Ma; Yu-Ting Gu; Tian-Qi Zhang; Zhi-Mei Huang; Zhen-Hai Lu; Yang-Kui Gu
Journal:  World J Surg Oncol       Date:  2017-07-27       Impact factor: 2.754

5.  Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.

Authors:  Alessandro Parisi; Alessio Cortellini; Katia Cannita; Olga Venditti; Floriana Camarda; Maria Alessandra Calegari; Lisa Salvatore; Giampaolo Tortora; Daniele Rossini; Marco Maria Germani; Alessandra Boccaccino; Emanuela Dell'Aquila; Claudia Fulgenzi; Daniele Santini; Michele De Tursi; Nicola Tinari; Pietro Di Marino; Pasquale Lombardi; Susana Roselló Keränen; Marisol Huerta Álvaro; Ina Valeria Zurlo; Domenico Cristiano Corsi; Alessandra Emiliani; Nicoletta Zanaletti; Teresa Troiani; Pasquale Vitale; Riccardo Giampieri; Filippo Merloni; Mario Alberto Occhipinti; Paolo Marchetti; Michela Roberto; Federica Mazzuca; Michele Ghidini; Alice Indini; Ingrid Garajova; Federica Zoratto; Simona Delle Monache; Giampiero Porzio; Corrado Ficorella
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

6.  Prognostic value of chloride channel accessory mRNA expression in colon cancer.

Authors:  Xiaohang Pan; Qiaoqi Wang; Chenfei Xu; Ling Yan; Sen Pang; Jialiang Gan
Journal:  Oncol Lett       Date:  2019-07-15       Impact factor: 2.967

7.  The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.

Authors:  Ki Yoon Doah; Ui Sup Shin; Byong Ho Jeon; Sang Sik Cho; Sun Mi Moon
Journal:  Ann Coloproctol       Date:  2021-04-30

8.  Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?

Authors:  Yakup Ergun; Oznur Bal; Mutlu Dogan; Gokhan Ucar; Merve Dirikoc; Yusuf Acikgoz; Ferhat Bacaksiz; Dogan Uncu
Journal:  J Res Med Sci       Date:  2020-02-20       Impact factor: 1.852

9.  Surgery improves the prognosis of colon mucinous adenocarcinoma with liver metastases: a SEER-based study.

Authors:  Jia Huang; Guodong Chen; Huan Liu; Yiwei Zhang; Rong Tang; Qiulin Huang; Kai Fu; Xiuda Peng; Shuai Xiao
Journal:  BMC Cancer       Date:  2020-09-23       Impact factor: 4.430

Review 10.  The challenges in colorectal cancer management during COVID-19 epidemic.

Authors:  Xianghai Ren; Baoxiang Chen; Yuntian Hong; Weicheng Liu; Qi Jiang; Jingying Yang; Qun Qian; Congqing Jiang
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.